Skip to content Skip to navigation

Three-drug combination found to treat MRSA

September 18, 2015
by Megan Combs, Associate Editor
| Reprints

A group of three antibiotics, not able to fight staphylococcus aureus (MRSA) on their own, can fight MRSA in combination, according to new research out of the Washington University School of Medicine in St. Louis. The findings were published in Medicinal Chemistry Communications

The three drugs, meropenem, piperacillin and tazobactam, have not been effective against MRSA for years. 

"MRSA infections kill 11,000 people each year in the United States, and the pathogen is considered one of the world’s worst drug-resistant microbes," principal investigator Gautam Dantas, PhD, told Outbreak News Today. "Using the drug combination to treat people has the potential to begin quickly because all three antibiotics are approved by the FDA."

Read the research here.

Memory Care Forum - Focus: Resident Care

Get the latest information on Resident Care, and attend other valuable sessions at this two-day event making education on the research, innovations, and program approaches to memory care a priority.

Philadelphia, May 23-24   |   San Diego, September 22-23